Pulse Biosciences, Inc.
PLSE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,385 | -$19,168 | -$16,795 | -$19,385 |
| Dep. & Amort. | $256 | $273 | $283 | $287 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $5,189 | $5,681 | $0 |
| Change in WC | $182 | $343 | -$2,690 | $3,155 |
| Other Non-Cash | $5,908 | $556 | $0 | $6,799 |
| Operating Cash Flow | -$13,039 | -$12,807 | -$13,521 | -$9,144 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$62 | -$103 | -$45 | -$53 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$20 | $0 | $0 |
| Investing Cash Flow | -$62 | -$123 | -$45 | -$53 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,966 | $0 | $14,807 | $48,202 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $1,966 | $0 | $14,807 | $48,202 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11,135 | -$12,930 | $1,241 | $39,005 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $106,349 | $119,279 | $118,038 | $79,033 |
| End Cash | $95,214 | $106,349 | $119,279 | $118,038 |
| Free Cash Flow | -$13,101 | -$12,910 | -$13,566 | -$9,197 |